These additional data served to identify physiological expression of IRX1 and MEIS1 in pro-B-cells and aberrant activity of IRX and MEIS genes in BCP-ALL patients and cell lines which were used to analyze regulatory relationships. The gene discussed is MEIS1; the disease is acute lymphoblastic leukemia.